One-Year Safety and Immunogenicity of Two Formulations of an Adjuvanted Varicella-Zoster Virus (VZV) Subunit Candidate Vaccine in Adult Autologous Hematopoietic Cell Transplant (HCT) Recipients
Biology of Blood and Marrow Transplantation- Netherlands
doi 10.1016/j.bbmt.2012.11.140
Full Text
Abstract
Available in
Date
February 1, 2013
Authors
Publisher
Elsevier BV